logo

AEMD

Aethlon Medical·NASDAQ
--
--(--)
--
--(--)
0.43 / 10
Underperform

Aethlon Medical Inc (AEMD) exhibits weak fundamentals, as evidenced by a comprehensive score of 0.4/10. Key concerns include a negative Price-to-Earnings ratio (-10.9392), an extremely high Price-to-Sales ratio (1339.4555), and negative profitability margins (Net Profit Margin -41.1131). These metrics place the stock in lower-performing quartiles, historically associated with negative monthly returns, and suggest limited financial health and growth prospects.

Fundamental(0.43)SentimentTechnical

Analysis Checks(2/10)

Revenue-MV
Value-0.22
Score2/3
Weight-4.80%
1M Return0.97%
PS
Value1339.46
Score0/3
Weight16.85%
1M Return-3.74%
PE
Value-10.94
Score0/3
Weight8.09%
1M Return-1.96%
GPM
Value0.20
Score0/3
Weight16.16%
1M Return-4.02%
Profit-MV
Value-0.01
Score2/3
Weight-9.51%
1M Return1.73%
GMAR
Value0.23
Score0/3
Weight19.36%
1M Return-4.71%
CFOA
Value-0.32
Score0/3
Weight19.69%
1M Return-5.12%
GPOA
Value0.10
Score0/3
Weight8.83%
1M Return-1.81%
NPM
Value-41.11
Score0/3
Weight16.72%
1M Return-4.40%
Cash-MV
Value-0.19
Score1/3
Weight8.61%
1M Return-1.88%
Is AEMD fundamentally strong?
  • AEMD scores 0.43/10 on fundamentals and holds a Premium valuation at present. Backed by its -59.78% ROE, 0.00% net margin, -0.17 P/E ratio, 0.38 P/B ratio, and 3.69% earnings growth, these metrics solidify its Underperform investment rating.